The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
The price of Verona Pharma Plc ADR (NASDAQ: VRNA) closed at $63.31 in the last session, up 2.10% from day before closing price of $62.01. In other words, the price has increased by $2.10 from its previous closing price. On the day, 1.19 million shares were traded.
Ratios:
We take a closer look at VRNA’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 10.48 and its Current Ratio is at 10.63. In the meantime, Its Debt-to-Equity ratio is 0.60 whereas as Long-Term Debt/Eq ratio is at 0.59.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Cantor Fitzgerald on April 21, 2025, initiated with a Overweight rating and assigned the stock a target price of $80.
On January 10, 2025, ROTH MKM started tracking the stock assigning a Buy rating and target price of $68.
On October 03, 2024, Wells Fargo started tracking the stock assigning a Overweight rating and target price of $50.Wells Fargo initiated its Overweight rating on October 03, 2024, with a $50 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Mar 12 ’25 when Rickard Kathleen A. sold 79,264 shares for $8.35 per share. The transaction valued at 661,942 led to the insider holds 2,608,976 shares of the business.
KATHLEEN RICKARD bought 9,908 shares of VRNA for $621,232 on Mar 12 ’25. On Dec 05 ’24, another insider, ZACCARDELLI DAVID, who serves as the President and CEO of the company, sold 640,264 shares for $5.01 each. As a result, the insider received 3,205,226 and left with 14,367,552 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 127.57 while its Price-to-Book (P/B) ratio in mrq is 26.19.
Stock Price History:
Over the past 52 weeks, VRNA has reached a high of $70.40, while it has fallen to a 52-week low of $11.39. The 50-Day Moving Average of the stock is 1.10%, while the 200-Day Moving Average is calculated to be 50.17%.
Shares Statistics:
A total of 84.63M shares are outstanding, with a floating share count of 74.18M. Insiders hold about 12.34% of the company’s shares, while institutions hold 69.87% stake in the company.
